Jeffrey V. Ravetch (left) and Andrew T. Jones (right) showed that the anti-inflammatory activity of IgG is enhanced by co-engagement of type I and II ...

Crystal Loos noticed that her young daughter began acting differently in the spring of 2023. By July 2024, her once bubbly ...

The Intravenous Immunoglobulin (IVIG) market across the 7MM was valued at around USD 7,384 million in 2025 and is expected to ...

SE stock is rated Hold due to valuation constraints and pipeline setbacks, despite strong commercial execution with VYVGART.

Kyverna Therapeutics stock upgraded to Strong Buy after positive phase 2 results for miv-cel in SPS and MG. Read the latest ...

PlasmaGen said the fresh capital will be used to expand its product portfolio, strengthen internal capabilities and support entry into international markets.

Could a single night change the life of a very enthusiastic and very happy little child beyond recognition? This is what an ...

LINKER-MM4 trial shows linvoseltamab monotherapy achieves a 79% overall response rate in newly diagnosed MM patients, with 92 ...

There are constantly new suggestions on how alloimmunized pregnancies should be managed. In a bid to ensure that current ...

Modifying existing phototherapy procedures, introducing adjunct therapies and changing light sources may improve HDFN ...

The Food and Drug Administration on Monday approved a pill version of the blockbuster weight-loss injectable drug Wegovy, ...

The Wegovy pill is one of two oral GLP-1 drugs expected to hit the market in the next few months; the other, from Lilly, is called orforglipron – until it receives a brand name – and is expected to be ...